Insiders · ICPT

ICPT insider transactions

Intercept Pharmaceuticals Inc. (ICPT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

ICPT insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Intercept Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Srinivas AkkarajuDirector+$5.02M
• Rocco VeneziaOfficer, since March 2021
• Paolo FundaroDirector
• M Michelle BerreyOfficer, since June 2021
• Linda M RichardsonOfficer, since February 2021
• Luca BenattiDirector
• Glenn SblendorioDirector
• Nancy Miller-RichDirector
• Gino SantiniDirector
• Dagmar Rosa-BjorkesonDirector, since April 2021
• Keith Michael GottesdienerDirector
• David A FordOfficer
• Jared FreedbergOfficer, since February 2021
• Daniel BradburyDirector
• Jerome Benedict DursoOfficer, Director
• Mark PruzanskiDirector
• Andrew SaikOfficer, since June 2021
• Bryan BallOfficer
• Gail CawkwellOfficer
• Lisa DeFrancescoOfficer, since February 2021
• Christian WeyerOfficer
• Sandip KapadiaOfficer
• Jason CampagnaOfficer

Recent Form 3, 4, and 5 filings for ICPT

• 1095d
  Akkaraju Srinivas returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Fundaro Paolo returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Venezia Rocco returned $278,711 worth of shares to the company (14,669 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Berrey M Michelle returned $984,010 worth of shares to the company (51,790 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Richardson Linda M returned $505,115 worth of shares to the company (26,585 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Benatti Luca returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Sblendorio Glenn returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Miller-Rich Nancy returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Santini Gino returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Rosa-Bjorkeson Dagmar returned $220,875 worth of shares to the company (11,625 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Gottesdiener Keith Michael returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Ford David A returned $406,600 worth of shares to the company (21,400 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Freedberg Jared returned $641,478 worth of shares to the company (33,762 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Bradbury Daniel returned $154,109 worth of shares to the company (8,111 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Durso Jerome Benedict returned $1,953,675 worth of shares to the company (102,825 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Pruzanski Mark closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1095d
  Saik Andrew returned $859,636 worth of shares to the company (45,244 units at $19.00), closing all direct ownership in the company (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1105d
  Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 1% to 56,443 units (SEC Form 4)

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1144d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 908 shares, decreasing direct ownership by 1% to 68,265 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1151d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 2% to 80,139 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1197d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 1% to 57,214 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1238d
  SEC Form 4 filed by Saik Andrew

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1245d
  SEC Form 4 filed by Berrey M Michelle

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Benatti Luca

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Sblendorio Glenn

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Gottesdiener Keith Michael

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Fundaro Paolo

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Santini Gino

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Rosa-Bjorkeson Dagmar

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Miller-Rich Nancy

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Bradbury Daniel

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1267d
  SEC Form 4 filed by Akkaraju Srinivas

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1289d
  SEC Form 4 filed by Freedberg Jared

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1330d
  SEC Form 4 filed by Saik Andrew

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1337d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 1% to 82,631 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1365d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 386 shares, decreasing direct ownership by 0.88% to 43,291 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1378d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 918 shares, decreasing direct ownership by 2% to 58,756 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Venezia Rocco was granted 9,800 shares, increasing direct ownership by 63% to 25,451 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Saik Andrew was granted 14,700 shares, increasing direct ownership by 26% to 70,990 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Richardson Linda M was granted 12,200 shares, increasing direct ownership by 39% to 43,677 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Freedberg Jared was granted 12,200 shares, increasing direct ownership by 26% to 59,674 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Ford David A was granted 9,800 shares, increasing direct ownership by 37% to 36,438 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Durso Jerome Benedict was granted 50,400 shares, increasing direct ownership by 48% to 154,640 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1381d
  SEC Form 4: Berrey M Michelle was granted 14,700 shares, increasing direct ownership by 21% to 83,877 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Venezia Rocco covered exercise/tax liability with 675 shares, decreasing direct ownership by 4% to 15,651 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 718 shares, decreasing direct ownership by 1% to 56,290 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 718 shares, decreasing direct ownership by 1% to 47,474 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 1,600 shares, decreasing direct ownership by 5% to 31,477 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Ford David A covered exercise/tax liability with 1,777 shares, decreasing direct ownership by 6% to 26,638 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Durso Jerome Benedict covered exercise/tax liability with 7,083 shares, decreasing direct ownership by 6% to 104,240 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1409d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 765 shares, decreasing direct ownership by 1% to 69,177 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1420d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 908 shares, decreasing direct ownership by 2% to 57,008 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1427d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 2% to 69,942 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1470d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 2% to 48,192 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1511d
  SEC Form 4: Saik Andrew covered exercise/tax liability with 908 shares, decreasing direct ownership by 2% to 57,916 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1518d
  SEC Form 4: Berrey M Michelle covered exercise/tax liability with 1,246 shares, decreasing direct ownership by 2% to 71,188 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1528d
  SEC Form 4: Venezia Rocco covered exercise/tax liability with 429 shares, decreasing direct ownership by 3% to 16,326 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1528d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 597 shares, decreasing direct ownership by 2% to 33,077 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1548d
  SEC Form 4: Richardson Linda M covered exercise/tax liability with 124 shares, decreasing direct ownership by 0.37% to 33,674 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)
• 1562d
  SEC Form 4: Freedberg Jared covered exercise/tax liability with 771 shares, decreasing direct ownership by 2% to 48,963 units

  4 - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer)